4 terminated, 3 unknown, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Retrospective Study of Keloid Disorder History of prior Surgery, History of Radiation Therapy - Keloid | Unknown | Tirgan, Michael H., M.D. | 5000 | 2016-09-01 | 2016-10-04 | |
| Sorafenib for Patients With Extensive Keloids Sorafenib - Keloids | Phase 2 | Terminated | Tirgan, Michael H., M.D. | 60 | 2013-03-01 | 2016-10-18 |
| Study of Psycho-Social Impact of Keloid Keloid | Terminated | Tirgan, Michael H., M.D. | 1000 | 2012-09-01 | 2016-10-18 | |
| Keloid Tissue Bank Keloid | Terminated | Tirgan, Michael H., M.D. | 78 | 2012-06-01 | 2014-11-18 | |
| Therapeutic Study of Bevacizumab Injection Directly Inside the Keloid Tissue bevacizumab - Keloid | Phase 2 | Terminated | Tirgan, Michael H., M.D. | 2 | 2012-02-01 | 2016-10-18 |
| Keloid Radiation Registry Keloid | Unknown | Tirgan, Michael H., M.D. | 1000 | 2011-12-01 | 2016-10-18 | |
| Web Based Investigation of Natural History of Keloid Disorder, an Online Survey Keloid | Recruiting | Tirgan, Michael H., M.D. | 10000 | 2011-11-01 | 2016-10-04 | |
| Epidemiology Study of Keloid Keloid | Unknown | Tirgan, Michael H., M.D. | 100000 | 2011-09-01 | 2016-10-18 |
Keloid (8) · Cicatrix, Hypertrophic (2) · Cicatrix (1)
Bevacizumab (1) · Radiotherapy (1) · Sorafenib (1) · Surgical Procedures, Operative (1)
United States (8)
Michael H Tirgan, MD (7) · Michael H. Tirgan, MD (1)